Phathom Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Phathom Pharmaceuticals, Inc. (PHAT) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.300.380.160.180.29
Cash & Short-Term Investments0.300.380.160.180.29
Accounts Receivable0.040.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.020.010.010.000.00
Total Current Assets0.360.400.160.190.29
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Long-Term Investments0.000.000.000.000.00
Other Non-Current Assets0.020.010.000.000.00
Total Non-Current Assets0.020.020.000.000.00
Total Assets0.380.410.160.190.30
Current Liabilities
Accounts Payable0.010.010.010.010.02
Short-Term Debt0.020.010.000.000.01
Current Portion of Long-Term Debt0.020.010.000.000.01
Accrued Liabilities0.040.020.010.010.03
Other Current Liabilities0.020.010.000.000.00
Total Current Liabilities0.090.040.030.020.06
Non-Current Liabilities
Long-Term Debt0.200.440.100.090.04
Other Non-Current Liabilities0.340.010.120.010.00
Total Non-Current Liabilities0.550.450.210.100.00
Total Liabilities0.630.490.240.120.10
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-1.26-0.93-0.73-0.53-0.39
Additional Paid-in Capital1.010.860.650.600.00
Shares Outstanding0.070.060.040.030.00
Total Stockholders' Equity-0.25-0.07-0.070.070.19
Total Liabilities & Equity0.380.410.160.190.00